Buy or sell Sano stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Sano Stock

Sano is developing a low cost, Point of Care diagnostic platform to early detect and intervene in at least 6 different diseases.

About Sano Stock

Sano is developing a low cost, Point of Care diagnostic platform to early detect and intervene in at least 6 different diseases affecting human and vet populations. Their first focus is human chronic wounds, such as diabetic foot ulcers and venous​​ leg ulcers, personalizing treatment to promote faster healing and avoid over $3B in treatment costs from trial and error and prolonged chronicity. They have tested their proprietary chemistry, have prototypes designed, and soon will start clinical trials and submit for regulatory clearance. "Low Cost" means that they not only anticipate faster adoption in the developed world, but also that their solution is truly a global solution, not one reserved for wealthy nations alone as obesity, diabetes, and aging population are trends affecting nearly every nation and sharply increase the incidence of chronic wounds.

Funding History

October 2014$50K

Management

Chief Scientific Officer

Dan Kerschensteiner

President

Paul Hayre

Chief Financial Officer

Jeff Farmer

Press

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Sano or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 80K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo